Cited by 559Barrier Structure and Function StudiesCell Adhesion Molecules ResearchProtease and Inhibitor Mechanisms

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

Open access
Agrawal, Smriti, Anderson, Per, Durbeej, Madeleine, van Rooijen, Nico, Ivars, Fredrik, Opdenakker, Ghislain, Sorokin, Lydia M.·2006·The Journal of Experimental Medicine

Abstract

The endothelial cell monolayer of cerebral vessels and its basement membrane (BM) are ensheathed by the astrocyte endfeet, the leptomeningeal cells, and their associated parenchymal BM, all of which contribute to establishment of the blood–brain barrier (BBB). As a consequence of this unique structure, leukocyte penetration of cerebral vessels is a multistep event. In mouse experimental autoimmune encephalomyelitis (EAE), a widely used central nervous system inflammatory model, leukocytes first penetrate the endothelial cell monolayer and underlying BM using integrin β1-mediated processes, but mechanisms used to penetrate the second barrier defined by the parenchymal BM and glia limitans remain uninvestigated. We show here that macrophage-derived gelatinase (matrix metalloproteinase [MMP]-2 and MMP-9) activity is crucial for leukocyte penetration of the parenchymal BM. Dystroglycan, a transmembrane receptor that anchors astrocyte endfeet to the parenchymal BM via high affinity interactions with laminins 1 and 2, perlecan and agrin, is identified as a specific substrate of MMP-2 and MMP-9. Ablation of both MMP-2 and MMP-9 in double knockout mice confers resistance to EAE by inhibiting dystroglycan cleavage and preventing leukocyte infiltration. This is the first description of selective in situ proteolytic damage of a BBB-specific molecule at sites of leukocyte infiltration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20051342

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metalloproteinases selectively cleave dystroglycan, which tethers astrocytic foot processes to the basement membrane, allowing penetration of effector T cells and myeloid cells into the CNS parenchyma in the MOG35-55 EAE model.

    “The metalloproteinases selectively cleave dystroglycan, which tethers astrocytic foot processes to the basement membrane (Fig. 3), allowing penetration of effector T cells and myeloid cells into the CNS parenchyma in the MOG35-55 EAE model (121).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [46]Dubois, B., S. Masure, U. Hurtenbach, L. Paemen, H. Heremans, J. van den Oord, R. Sciot, T. Meinhardt, G. Hammerling, G. Opdenakker, and B. Arnold. 1999. Resistance of young gelatinase B-deficient mice to EAE and necrotizing tail lesions. J. Clin. Invest. 104: 1507–1515. 10587514 PMC409857

Cited by

Sorted by citations

Authors
Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., & Sorokin, L. M.
Affiliations
  • 1Experimental Pathology
  • 2Immunology,
  • Lund University (SE)
  • 4Vrije Universiteit, Molecular Cell Biology, 1081 BT Amsterdam, Netherlands
  • Rega Institute for Medical Research (BE)
  • University of Münster (DE)
Venue
The Journal of Experimental Medicine
Published
2006-04-03
Volume
203
Issue
4
Pages
1007-1019
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2154793195
Cited by
559
References
49
Citations by year
2026: 11 · 2025: 22 · 2024: 33 · 2023: 22 · 2022: 23 · 2021: 29 · 2020: 19 · 2019: 18 · 2018: 31 · 2017: 31 · 2016: 37 · 2015: 30 · 2014: 31 · 2013: 38 · 2012: 37
FWCI
17.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Multiple Sclerosis Society
  • Fondation Charcot
  • Vlaamse regering
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
dystroglycan, experimental autoimmune encephalomyelitis, leukocyte transmigration, blood-brain barrier, MMP-2, MMP-9, astrocyte endfeet, laminin, perlecan, agrin, beta1 integrin, leukocyte infiltration
MeSH terms
Animals, Astrocytes, Basement Membrane, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Hydrolysis, Leukocytes, Macrophages, Mice, Inbred C57BL, Gelatinases, Mice, Knockout, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Leukocyte Rolling, Dystroglycans, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review